Publicacións (187) Publicacións de JOSE MANUEL CAMESELLE TEIJEIRO

filter_list

2026

  1. Adrenal mixed corticomedullary tumors: report of a case with molecular characterization and systematic review

    Virchows Archiv, Vol. 488, Núm. 2, pp. 367-375

  2. Integration of multi-omics data uncovers novel germline susceptibility candidates in early-onset colorectal cancer

    European Journal of Human Genetics

  3. MLH1 promoter methylation, mismatch repair and intestinal differentiation markers in papillary thyroid carcinoma: real-world evidence from Galicia (Northwest Spain)

    Virchows Archiv

  4. SEAP-GETNE consensus on prognostic and predictive molecular biomarkers in thyroid cancer

    Revista Espanola de Patologia, Vol. 59, Núm. 2

  5. Tracing the molecular route to progression in miRNA-biogenesis-defective thyroid lesions

    JCI insight, Vol. 11, Núm. 3

2025

  1. Aggressive prolactinomas in men are associated with visual disturbances and pituitary hormone deficiencies

    Scientific Reports, Vol. 15, Núm. 1

  2. Challenges of the 5th Edition of the WHO Classification of Thyroid Tumours

    ENDOCRINOLOGY INSIGHTS, Vol. 20, Núm. 2, pp. 92-100

  3. DICER1-Related Pediatric Thyroid Neoplasm with Follicular and Morular Growth: A Tumor that Did Not Read the Textbook

    Endocrine Pathology, Vol. 36, Núm. 1

  4. Focal High-Grade Areas with a Tumor-in-Tumor Pattern: Another Feature of Pediatric DICER1-Associated Thyroid Carcinoma?

    Endocrine Pathology, Vol. 36, Núm. 1

  5. Histopathology of C Cells and Medullary Thyroid Carcinoma

    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, Vol. 223, pp. 9-50

  6. New Insights into the Clinical Characterization of SDHAF2-related Familial Paraganglioma Syndrome

    Journal of Clinical Endocrinology and Metabolism, Vol. 110, Núm. 11, pp. e3635-e3647

  7. Next-Generation Sequencing (NGS) in non-small cell lung carcinoma: A real-world experience in the public health system of Galicia (Northwest Spain)

    PLOS ONE, Vol. 20, Núm. 7 July

2024

  1. Clinical Advantages and Limitations of Tumors Displaying Minimal and Extensive Vascular Invasion

    Thyroid FNA Cytology: Differential Diagnoses and Pitfalls, Third Edition (Springer Nature), pp. 119-130

  2. Correction to: Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial (Nature Communications, (2024), 15, 1, (5251), 10.1038/s41467-024-49121-3)

    Nature Communications

  3. Correction to: dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe (Nature Communications, (2024), 15, 1, (3736), 10.1038/s41467-024-47751-1)

    Nature Communications

  4. Cribriform morular thyroid carcinoma: Clinicopathological and molecular basis for both a preventive and therapeutic approach for a rare tumor (Review)

    Oncology reports, Vol. 52, Núm. 3

  5. dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe

    Nature Communications, Vol. 15, Núm. 1

2023

  1. Cribriform morular thyroid carcinoma: a case report with pathological, immunohistochemical, and molecular findings suggesting an origin from follicular cells (or their endodermal precursors)

    Virchows Archiv, Vol. 482, Núm. 3, pp. 615-623

  2. Should we suspect primary aldosteronism in patients with hypokalaemic rhabdomyolysis? A systematic review

    Frontiers in Endocrinology, Vol. 14

2022

  1. Adrenal Medullary Hyperplasia: An Under the Radar Cause of Endocrine Hypertension

    American Journal of the Medical Sciences, Vol. 363, Núm. 1, pp. 64-68